# Mga baryante ng SARS-CoV-2

Ang SARS-CoV-2 baryants na nagsasanhi ng COVID-19 sa mundo sa kasalukuyan
Positive, negative, and neutral mutations during the evolution of coronaviruses like SARS-CoV-2.
Ang **Mga baryante ng SARS-CoV-2** ay ang mga baryante ng SARS-CoV-2 na nagsanhi ng pandemya sa mundo bunsod ng COVID-19, bawat bansa ay nakitaan ng mutution mula sa mga strain ng SARS-CoV-2 na nag mula sa Wuhan, Hubei, Tsina noong 1 Disyembre 2019. Ang mga baryante ng SARS-CoV-2 ay ang mga sanga'ng anak dahil sa pag mutate ng birus, ang iba't ibang baryante ay mayroong kakayahang kumopya ng kawangis upang magparami, mayroong mga baryante ay nagkakamali ng pagkopya mula sa strain na ito o tinatawag na "error spelled". ito ay hindi na maaring magpakalat ng baryant.

## Talahanayan ng Pangkalahatang ideya

5 Variant of concern
**A** Alpha

**B** Beta

**G** Gamma

**D** Delta

**O** Omicron

| Unang deteksyon | PANGOLIN nomenclature | Ibang pangalan | Notable mutations | Evidence of clinical changes | Pagkalat | Sang. |
| --- | --- | --- | --- | --- | --- | --- |
|  United Kingdom | 2020 Pebrero | Global | B.1.1.7 | 20I/501Y.V1 | VOC-20DEC-01 | — | N501Y, 69–70del, P681H | Padron:Estimate higher | Padron:Estimate more lethal | No change |
|  Nigeria | 2020 Agosto | Global | B.1.1.207 | — | — | — | P681H | No evidence of change | No evidence of change | *Under investigation* |
|  United States | 2020 Hunyo | Global | B.1.429, B.1.427 | 20C/S:452R | — | CAL.20C | I4205V, D1183Y, S13I, W152C, L452R | Padron:Estimate (18.6%–24.2%) higher | *Under investigation* | Moderate-to-severe reduction in neutralisation |
|  South Africa | 2020 Oktubre | Global | B.1.351 | 20H/501Y.V2 | VOC-20DEC-02 | 501Y.V2 | N501Y, K417N, E484K | Padron:Estimate higher | No evidence of change | Significant reduction in neutralisation by antibodies |
|  India | 2020 Oktubre | Global | B.1.617 | — | VUI-21APR-01 | — | E484Q, L452R, P681R | *Under investigation* | *Under investigation* | Slight reduction in effective neutralisation |
|  Japan  Brazil | 2020 Disyembre | Global | P.1 | 20J/501Y.V3 | VOC-21JAN-02 | B.1.1.28.1 | N501Y, E484K, K417T | Padron:Estimate higher | Padron:Estimate more lethal | Overall reduction in effective neutralisation |
|  United Kingdom  Nigeria | 2020 Disyembre | Global | B.1.525 | 20C | VUI-21FEB-03 |
| E484K, F888L | *Under investigation* | *Under investigation* | Possibly reduced neutralisation |
|  India | 2021 Octubre | Global | AY.4.2 |  |  |

## Kilalang baryante

|  |  |  |  |  |
| --- | --- | --- | --- | --- |
| **Taon** | **WHO Greek lebel** | **Baryante** | **Pamagat** | **Pinagmulan** |
| 2019 | 2019-nCoV **c** | *SARSr-CoV*  | Pandemya ng COVID-19 (COVID-19) | Wuhan, Tsina |
| 2020 | Alpha  **α** | SARS-CoV-2 Alpha variant | Pagkalat ng B.1.1.7 ng 2020 (COVID-19) | Kent, United Kingdom |
| Beta  **β** | SARS-CoV-2 Beta variant | Pagkalat ng 501.V2 (COVID-19) | Silangang Cape, Timog Aprika |
| 2021 | Gamma **Γ** | SARS-CoV-2 Gamma variant | Pagkalat ng Lineage P.1 (COVID-19) | Manaus, Brazil |
| Delta **Δ** | SARS-CoV-2 Delta variant | Pagkalat ng B.1.617.2 (COVID-19) | New Delhi, India |
| Delta **δ** | SARS-CoV-2 Delta Plus variant | Pagkalat ng B.1.617.2 (COVID-19) | Nepal & Maharashtra, India |
| 2020 | Epsilon **ε** | SARS-CoV-2 Epsilon variant | Pagkalat ng CAL.20C (COVID-19) | Los Angeles, California, USA |
| 2021 | Zeta **ζ** | SARS-CoV-2 Zeta variant | Pagkalat ng Lineage P.2 (COVID-19) | Rio de Janeiro, Brazil |
| 2020 | Eta **η** | SARS-CoV-2 Eta variant | Pagkalat ng Lineage B.1.525 (COVID-19) | Lagos, Nigeria |
| B.1.1.207 | Lineage B.1.1.207 | Pagkalat ng Lineage B.1.1.207 (COVID-19) | Nigeria |
| **ΔFVI** | SARS-CoV-2 Cluster 5 variant | Pagkalat ng Cluster 5 (COVID-19) | Hilagang Jutland, Denmark |
| 2021 | B.1.1.7 w/ E484K | Lineage B.1.1.318 | Pagkalat ng B.1.1.318 (COVID-19) | United Kingdom |
| Theta **Θ** | SARS-CoV-2 Theta variant | Pagkalat ng Lineage P.3 (COVID-19) | Cebu, Pilipinas |
| 2020 | Iota **ι** | SARS-CoV-2 Iota variant | Pagkalat ng B.1.526 (COVID-19) | Lungsod ng Bagong York, USA |
| 2021 | Kappa **κ** | SARS-CoV-2 Kappa variant | Pagkalat ng Lineage B.1.617 (COVID-19) | Delhi, India |
| Lambda **Λ** | SARS-CoV-2 Lambda variant | Pagkalat ng Lineage C.37 (COVID-19) | Lima, Peru |
| Mu **μ** | SARS-CoV-2 Mu variant | Pagkalat ng Lineage B.1.621 (COVID-19) | Colombia |
| C.1.2 | SARS-CoV-2 Lineage C.1.2 | Pagkalat ng Lineage C.1.2 (COVID-19) | Timog Aprika |
| AY.4.2 | SARS-CoV-2 Delta Subvariant | Pagkalat ng Lineage AY.4.2 (COVID-19) | India |
| Omicron **O** | SARS-CoV-2 Omicron variant | Pagkalat ng Lineage B.1.1.259 (COVID-19) | Botswana |
| 2022 | IHU | SARS-CoV-2 Ihu variant | Pagkalat ng Lineage B.1.640.2 (COVID-19) | Marseille, Pransya |
| BA.2 | SARS-CoV-2 Omicron Subvariant | Pagkalat ng Lineage BA.2 (COVID-19) | Denmark, Europa |
| AY.4.2 | SARS-CoV-2 Deltacron variant | Pagkalat ng Deltacron (COVID-19) | Cyprus |
| BA1 & BA.2 | SARS-CoV-2 Xe variant | Pagkalat ng XE variant (COVID-19) | United Kingdom |

## Mga iba't ibang pag-aalala (WHO)

Kategorya ng baryante

**3** Variant of concern

**2** Variant of interest

**1** Variant of old interest

| ​SARS-CoV-2 strain  |
| --- |
| Alpha  | Beta  | Gamma  | Delta  | **Delta + *(aktibo)  |
| *Delta Sub+*  | Epsilon  | Zeta  | Eta  | Theta  |
| Iota  | Kappa  | Lambda  | Mu  | Nu *(unused)* |
| Xi *(unused)* | *Omicron* | Pi | Rho | Sigma |
| Tau | Upsilon | Phi | Chi | Psi |
| Omega | **Griyegong alpabeto** |

### Mga ibang kilalang baryant

R.1
Lineage B.1.1.207
Lineage B.1.620
#### Dinagdag na baryante

* Lineage B.1.618
* Lineage B.1.1.318
* Lineage B.1.1.317
* Lineage C.1.2
* Lineage B.1.640.2

#### *Kilalang mutasyon*

* N440K
* L452R
* S477G/N
* E484Q
* E484K
* N501Y
* D614G
* P681H
* P681R
* A701V

## Tingnan rin

* COVID-19
* Pandemya ng COVID-19

## Talababa

## Sanggunian